RCA
BIB icon

Ranch Capital Advisors’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Ranch Capital Advisors’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-296
Closed -$28K – 198
2021
Q3 		$28K Hold
296
– – 0.02% 332
2021
Q2 		$29K Buy
296
+16
+6% +$1.4K 0.02% 409
2021
Q1 		$23K Hold
280
– – 0.02% 438
2020
Q4 		$24K Hold
280
– – 0.02% 426
2020
Q3 		$19K Hold
280
– – 0.02% 463
2020
Q2 		$19K Sell
280
-280
-50% -$17.9K 0.01% 479
2020
Q1 		$25K Sell
560
-100
-15% -$5.57K 0.02% 399
2019
Q4 		$41K Buy
+660
New +$35.2K 0.03% 372

Other funds holding BIB

OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ranch Capital Advisors's BIB Position: Q4 2021 in Review

Ranch Capital Advisors sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q4 2021, closing a stake of 296 shares — an estimated $28K sold.

Ranch Capital Advisors first reported a position in BIB in Q4 2019 and held it in 8 quarters. The position peaked at $41K in Q4 2019. 37 funds tracked by Wall St. Rank hold BIB as of Q4 2021.

  • Ranch Capital Advisors reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q4 2021 after selling out during the quarter.
  • Ranch Capital Advisors sold 296 ProShares Ultra NASDAQ Biotechnology shares in Q4 2021, an estimated $28K.
  • Ranch Capital Advisors first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2019 and held it in 8 quarters.
  • Ranch Capital Advisors's ProShares Ultra NASDAQ Biotechnology position peaked at $41K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2021.

Based on Ranch Capital Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.